Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) have earned an average rating of “Buy” from the nine analysts that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to […]
28 Sep 09:48 · The Markets Daily